相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immune Signatures Predict Prognosis in Localized Cancer
David S. Hsu et al.
CANCER INVESTIGATION (2010)
Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments
Ilona Kryczek et al.
BLOOD (2009)
Integrated Data From 2 Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trials of Active Cellular Immunotherapy With Sipuleucel-T in Advanced Prostate Cancer
Celestia S. Higano et al.
CANCER (2009)
A systematic review of humoral immune responses against tumor antigens
Miriam Reuschenbach et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Antitumor effects and immunoregulation mechanisms of IL-23 gene in mouse mammary cancer mediated by retrovirus
Lihua Liu et al.
CELLULAR IMMUNOLOGY (2009)
Long-lasting cross-presentation of tumor antigen in human DC
Florence Faure et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
IMMUNITY (2009)
Tumor Regression following DNA Vaccination and Regulatory T Cell Depletion in neu Transgenic Mice Leads to an Increased Risk for Autoimmunity
Jennifer B. Jacob et al.
JOURNAL OF IMMUNOLOGY (2009)
The combination of IL-21 and IFN-α boosts STAT3 activation, cytotoxicity and experimental tumor therapy
Karsten W. Eriksen et al.
MOLECULAR IMMUNOLOGY (2009)
Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen
Andreas Brave et al.
VACCINE (2009)
CTLA-4 Blockade with Monoclonal Antibodies in Patients with Metastatic Cancer: Surgical Issues
Giao Q. Phan et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Tumor protection following vaccination with low doses of lentivirally transduced DCs expressing the self-antigen erbB2
Miriam E. Mossoba et al.
MOLECULAR THERAPY (2008)
A self-adjuvanting lipopeptide-based vaccine candidate for the treatment of hepatitis C virus infection
Brendon Y. Chua et al.
VACCINE (2008)
Taming cancer by inducing immunity via dendritic cells
A. Karolina Palucka et al.
IMMUNOLOGICAL REVIEWS (2007)
Maximizing CD8+ T cell responses elicited by peptide vaccines containing CpG oligodeoxynucleotides
James N. Kochenderfer et al.
CLINICAL IMMUNOLOGY (2007)
Trastuzumab: triumphs and tribulations
R. Nahta et al.
ONCOGENE (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance
Gang Zhou et al.
JOURNAL OF IMMUNOLOGY (2007)
Towards progress on DNA vaccines for cancer
D. B. Lowe et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2007)
Immunosuppressive therapy and malignancy in organ transplant recipients - A systematic review
Alex Gutierrez-Dalmau et al.
DRUGS (2007)
Prime-boost with alternating DNA vaccines designed to engage different antigen presentation pathways generates high frequencies of peptide-specific CD8+ T cells
Joanna N. Radcliffe et al.
JOURNAL OF IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Paradoxical roles of the immune system during cancer development
KE de Visser et al.
NATURE REVIEWS CANCER (2006)
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
H Park et al.
NATURE IMMUNOLOGY (2005)
Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages
LE Harrington et al.
NATURE IMMUNOLOGY (2005)
Cross-presentation: underlying mechanisms and role in immune surveillance
KL Rock et al.
IMMUNOLOGICAL REVIEWS (2005)
Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals
M Chiyo et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Electroporation as a prime/boost strategy for naked DNA vaccination against a tumor antigen
S Buchan et al.
JOURNAL OF IMMUNOLOGY (2005)
Targeted delivery of the ErbB2/HER2 tumor antigen to professional APCs results in effective antitumor immunity
F Rohrbach et al.
JOURNAL OF IMMUNOLOGY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity
YK He et al.
JOURNAL OF IMMUNOLOGY (2005)
A listing of human tumor antigens recognized by T cells: March 2004 update
L Novellino et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
In vitro simian virus 40 large tumor antigen expression correlates with differential immune responses following DNA immunization
DB Lowe et al.
VIROLOGY (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
DNA vaccination against tumors
GJ Prud'homme
JOURNAL OF GENE MEDICINE (2005)
Immunotherapeutic uses of CpG oligodeoxynucleotides
DM Klinman
NATURE REVIEWS IMMUNOLOGY (2004)
The immunobiology of cancer immunosurveillance and immunoediting
GP Dunn et al.
IMMUNITY (2004)
Anti-idiotype responses abrogate anti-CD4-induced tolerance to a tumor-specific antigen and promote systemic tumor immunity
RC Kennedy et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance
YP Yang et al.
NATURE IMMUNOLOGY (2004)
The regulatory T cell family: Distinct subsets and their interrelations
H Jonuleit et al.
JOURNAL OF IMMUNOLOGY (2003)
Targeting cyclooxygenase-2 in human neoplasia: Rationale and promise
AJ Dannenberg et al.
CANCER CELL (2003)
Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
MR Smith
ONCOGENE (2003)
Induction of systemic immunity by expression of interleukin-23 in murine colon carcinoma cells
YQ Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Therapeutic LMP1 polyepitope vaccine for EBV-assolciated Hodgkin disease and nasopharyngeal carcinoma
J Duraiswamy et al.
BLOOD (2003)
Immunotherapy: past, present and future
TA Waldmann
NATURE MEDICINE (2003)
Expression of the interleukin-21 gene in murine colon carcinoma cells generates systemic immunity in the inoculated hosts
S Ugai et al.
CANCER GENE THERAPY (2003)
Genetic engineering of T cell specificity for immunotherapy of cancer
RA Willemsen et al.
HUMAN IMMUNOLOGY (2003)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
V Shankaran et al.
NATURE (2001)
Association of cancer with AIDS-related immunosuppression in adults
M Frisch et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
CTLA-4 blockade enhances the CTL responses to the p53 self-tumor antigen
J Hernández et al.
JOURNAL OF IMMUNOLOGY (2001)
Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells
K Tasaki et al.
CANCER GENE THERAPY (2000)
Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts
K Tasaki et al.
CANCER GENE THERAPY (2000)
Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer
K Song et al.
GENE THERAPY (2000)
分享论文
